Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
- Roberto Di Gesù†1,
- Maria Luisa Bondì†2Email author,
- Antonina Azzolina3,
- Emanuela Fabiola Craparo4,
- Chiara Botto4,
- Erika Amore2,
- Gaetano Giammona4 and
- Melchiorre Cervello3
© The Author(s) 2018
Received: 1 December 2017
Accepted: 1 December 2017
Published: 13 January 2018
The original article was published in Journal of Nanobiotechnology 2014 12:21
Correction to: Journal of Nanobiotechnology 2014, 12:21 https://doi.org/10.1186/1477-3155-12-21
Following publication of our article , we became aware that Roberto Di Gesù had been omitted from the list of authors. The corrected author list and authors’ contribution statement appear below. We apologize for any inconvenience this may have caused.
Corrected author list
Roberto Di Gesù, Maria Luisa Bondì, Antonina Azzolina, Emanuela Fabiola Craparo, Chiara Botto, Erika Amore, Gaetano Giammona, Melchiorre Cervello
Corrected Authors’ contributions
CB and EA are the Ph.D. students who carried out the laboratory work. AA carried out the biological work in laboratory. MC was the supervisor of the biological study and helping to develop the study parameters and design. RDG performed principal and most important analysis in the chemical and pharmaceutical studies. He produced materials and analyzed data showed in this work. MLB was the principal, scientific supervisor of the study. She conceived the study, supervised the students in the laboratory, directed the analysis and wrote the manuscript. EFC and GG have revised the final version of manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.